Open AccessFluvoxamine for Acute COVID-19 Infection: Weak Hypothesis, Predictable Failure
Author(s) -
Peter Manu
Publication year - 2022
Publication title -
american journal of therapeutics
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.349
H-Index - 62
eISSN - 1536-3686
pISSN - 1075-2765
DOI - 10.1097/mjt.0000000000001502
Subject(s) - fluvoxamine , medicine , placebo , randomized controlled trial , sertraline , clinical trial , psychiatry , fluoxetine , antidepressant , anxiety , serotonin , alternative medicine , pathology , receptor